LILRA4 antibody (AA 289-424)
Quick Overview for LILRA4 antibody (AA 289-424) (ABIN7158260)
Target
See all LILRA4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 289-424
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Leukocyte immunoglobulin-like receptor subfamily A member 4 protein (289-424AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LILRA4 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 4 (LILRA4))
-
Alternative Name
- LILRA4
-
Background
-
Background: May act as receptor for class I MHC antigens. Ligand binding leads to the activation of eosinophils and to the release of RNASE2, IL4 and leukotriene C4.
Aliases: CD85 antigen-like family member G antibody, CD85g antibody, ILT-7 antibody, ILT7 antibody, Immunoglobulin like transcript 7 antibody, Immunoglobulin-like transcript 7 antibody, Leukocyte immunoglobulin-like receptor subfamily A member 4 antibody, LILRA4 antibody, LIRA4_HUMAN antibody, MGC129597 antibody, MGC129598 antibody
-
UniProt
- P59901
Target
-